SARS-CoV-2 Nucleocapsid Protein (Omicron B.1.1.529 Variant)

Proteins and Peptides

SARS-CoV-2 Nucleocapsid Protein (Omicron B.1.1.529 Variant)

E. coli

Sequence Fragment: Met1-Ala419
Tag: N-terminal His tag

Virus

Calculated MW: 46.31 kDa

Recombinant

> 90% (SDS-PAGE)

50 µg

100 µg

1 mg

SDS-PAGE

Prior to lyophilization: PBS, pH 7.5, 0.02 % NLS, 1mM EDTA, 4 % Trehalose, 1 % Mannitol

Shipped within 5-10 working days.

Store at -20 °C to -80°C. Avoid repeated freeze/thaw cycles.
Shelf Life: 12 months.

No

UFO69279.1

Protein SARS-CoV-2

RUO

THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Standard Form: A DNA sequence encoding the SARS-CoV-2 Nucleocapsid (YP_009724397.2, with mutations P13L, ERS31-33 deletion, R203K, G204R) (Met1-Ala419) was expressed with a polyhistidine tag at the N-terminus. The mutations were identified in the SARS-CoV-2 variant (known as variant B.1.1.529) which emerged in the South Africa.